Skip to main content

Table 1 Baseline characteristics of the 18 patients at study inclusion

From: Ultraprotective ventilation allowed by extracorporeal CO2 removal improves the right ventricular function in acute respiratory distress syndrome patients: a quasi-experimental pilot study

Variables (units) Median (IQR)
Sex (male/female) 13/5
Age (years) 64 (57–76)
Body mass index (kg/m2) 28 (24–31)
SAPS II at admission 42 (39–45)
SOFA score at ECCO2R insertion 6 (5–8)
PaO2/FiO2 (mmHg) at ECCO2R initiation 117 (100–136)
Comorbidities, n (%)
 Arterial hypertension 6 (33.3)
 Chronic heart failure 6 (33.3)
 Diabetes 5 (27.8)
 Chronic renal impairment 2 (11.1)
 Chronic obstructive pulmonary disease 0 (0)
Cause of ARDS, n (%)
 Pneumonia 15 (83.3)
 Documented germs 12 (66.7)
 Influenza 7 (38.9)
 Others 5 (27.8)
 Pulmonary contusion 1 (5.5)
 Drug-induced pneumonia 1 (5.5)
 Neoplastic lung disease 1 (5.5)
Pre-ECCO2R adjuvant therapy, n (%)
 Neuromuscular blockade 17 (94.4)
 Prone positioning 8 (44.4)
 Nitric oxide 0 (0)
 Recruitment maneuvers 0 (0)
 Time from ICU admission to ECCO2R initiation (days) 2.5 (1–4)
 Time from intubation to ECCO2R initiation (days) 2 (1–3.8)
  1. ARDS acute respiratory distress syndrome, ECCO2R extracorporeal CO2 removal, SOFA Sequential Organ Failure Assessment, SAPS Simplified Acute Physiologic Score, IQR interquartile range (25–75%)